Customer Service
About Us
Quality Control
Privacy Policy

Search:

For:



Back to Pure NewsCaps Home 03/26/2008


Featured Articles

-Cleanse Program: Four-Week Toxin Cleanse

-The FOOT Plan – Fully-Optimized Osteoporosis Therapy

What's New in March?

-Ubiquinol-QH
-Kidney Support Formula
-Nerve Support Formula
-Aller-Essentials
-Lutein/Zeaxanthin
-Tri-Alkali
-Glucomannan

Product Highlights

-Read more about our weekly product specials

Featured Abstracts

-Potassium citrate promotes acid-alkaline balance and healthy bone mineralization...*

-Konjac glucomannan supports healthy lipid and glucose metabolism by enhancing sterol and bile acid excretion...*

-Zeaxanthin intake declines with age, which may be a key factor for macular health...*

-Tinospora cordifolia promoted immune health and nasal function in this randomized double blind placebo controlled trial...*

-Alpha lipoic acid helps maintain neuronal cell health and cognitive function over a 4-year period as indicated by neuropsychological tests...*

Frequently Asked Questions

-How is ubiquinol different from CoQ10?



Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects--a randomized double-blind trial

OBJECTIVES: The present study was designed to evaluate effects of konjac glucomannan (KGM) supplement (3.6 g/day) for 28 days on blood lipid and glucose levels in hyperlipidemic type 2 diabetic patients and the possible mechanism for the reductions in blood lipid levels. METHODS: Twenty-two diabetic subjects (age 64.2 + 8.4 years, BMI 25.5 + 3.2 kg/m(2)) with elevated blood cholesterol levels (fasting glucose between 6.7-14.4 mmol/L), but currently not taking lipid-lowering medication, were recruited to participate in a two 28-day period, randomized, double-blind, crossover clinical trial. Fasting blood samples drawn on the initial and final days of each period were determined for plasma lipids and glucose levels. Feces collected at the end of each experimental period were analyzed for neutral sterol and bile acid contents. RESULTS: Compared with placebo, KGM effectively reduced plasma cholesterol (11.1%, p = 0.0001, adjusted alpha = 0.006), LDL-cholesterol (20.7%, p = 0.0004, adjusted alpha = 0.006), total/HDL cholesterol ratio (15.6%, p = 0.0005, adjusted alpha = 0.007), ApoB (12.9%, p = 0.0001, adjusted alpha = 0.006) and fasting glucose (23.2%, p = 0.002, adjusted alpha = 0.008). Plasma triglyceride, HDL-cholesterol, LDL/HDL cholesterol, postprandial glucose and body weight were not significant after adjustment by the Bonferroni-Hochberg procedure. Fecal neutral sterol and bile acid concentrations were increased by 18.0% (p = 0.004) and 75.4% (p < 0.001), respectively, with KGM supplement. CONCLUSIONS: The KGM supplement improved blood lipid levels by enhancing fecal excretion of neutral sterol and bile acid and alleviated the elevated glucose levels in diabetic subjects. KGM could be an adjunct for the treatment of hyperlipidemic diabetic subjects. Chen HL, Sheu WH, Tai TS, Liaw YP, Chen YC. J Am Coll Nutr. 2003 Feb;22(1):36-42.


For educational purposes only. Consult your physician for any health problems.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


home  |  disclaimer  |  privacy policy  |  contact us  |  about pure